NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NEI E-195-2020-0-US-01 Sensitive And Economic RNA Virus Detection Using A Novel RNA Preparation Method US 63/065,931 Abandoned
NIA E-139-2012-2-US-15 METHODS OF REGULATING CANNABINOID RECEPTOR ACTIVITY-RELATED DISORDERS AND DISEASES US CON 16/992,742 11389415 Issued PDF
NCI E-046-2019-0-US-06 Non-aggregating Heptamethine Cyanine Fluorophores For In Vivo Imaging US National Stage 16/969,902 10961193 Issued PDF
NIBIB E-054-2018-0-US-06 CHEMICAL CONJUGATES OF EVANS BLUE DERIVATIVES AND THEIR USE AS RADIOTHERAPY AND IMAGING AGENTS FOR TARGETING US National Stage 16/969,673 Pending
NCI E-107-2020-0-US-01 IGG4 HINGE-CONTAINING CHIMERIC ANTIGEN RECEPTORS TARGETING GLYPICAN-1 (GPC1) FOR TREATING SOLID TUMORS US 63/065,388 Abandoned
NIAID E-035-2018-0-US-03 TREATMENT OF INFECTIONS AND IMMUNE DYSREGULATION IN PATIENTS WITH PRIMARY IMMUNE DEFICIENCIES USING MRNA-CORRECTED AUTOLOGOUS GRANULOCYTES, LYMPHOCYTES AND/OR NATURAL KILLER CELLS US National Stage 16/968,792 Pending
NIDDK E-028-2018-1-CN-04 HETEROCYCLIC P2Y14 RECEPTOR ANTAGONISTS CN National Stage 201980012696.0 Abandoned
NIAID E-105-2020-0-US-01 Replication-Competent Adenovirus Type 4-HIV Env Vaccines And Their Use US 63/063,810 Abandoned
NCATS E-200-2020-0-US-01 REAL-TIME CELLULAR THERMAL SHIFT ASSAY (RT-CETSA) FOR RESEARCH AND DRUG DISCOVERY US 63/063,689 Abandoned
NIDA E-023-2018-0-US-04 DREADD ACTUATORS US National Stage 16/968,437 11739063 Issued PDF
NCI E-068-2018-0-AU-03 TETHERED INTERLEUKIN-15 AND INTERLEUKIN-21 AU National Stage 2019218785 Pending
NIDDK E-028-2018-1-CA-03 HETEROCYCLIC P2Y14 RECEPTOR ANTAGONISTS CA National Stage 3090788 Abandoned
NCI E-068-2018-0-CN-04 TETHERED INTERLEUKIN-15 AND INTERLEUKIN-21 CN National Stage 201980012443.3 Pending
NCI E-126-2019-0-PCT-02 T CELLS HAVING ENHANCED ANTI-TUMOR ACTIVITY PCT PCT PCT/US2020/045100 Expired
NIDDK E-028-2018-1-JP-06 HETEROCYCLIC P2Y14 RECEPTOR ANTAGONISTS JP National Stage 2020-542580 Abandoned
NCI E-176-2014-0-SA-54 Anti-Human Papillomavirus 16 E7 T Cell Receptors SA DIV 520412601 Pending
NCI E-041-2018-0-US-04 A METHOD OF TREATING TRIPLE-NEGATIVE BREAST CANCER US National Stage 16/967,472 Pending
NHLBI E-036-2015-1-US-03 NK CELLS WITH AN INCREASED ANTIBODY-DEPENDENT CELLULAR TOXICITY (ADCC) AGAINST TUMORS US DIV 16/985,797 Pending
NCI E-068-2018-0-CA-07 TETHERED INTERLEUKIN-15 AND INTERLEUKIN-21 CA National Stage 3090512 Pending
NCI E-080-2018-0-US-09 NANOPARTICLE-HYDROGEL COMPOSITE FOR NUCLEIC ACID MOLECULE DELIVERY US National Stage 16/967,302 11904057 Issued PDF
NIDDK E-028-2018-1-US-07 HETEROCYCLIC P2Y14 RECEPTOR ANTAGONISTS US National Stage 16/967,177 11584736 Issued PDF
NICHD E-185-2020-0-US-01 MULTIDIMENSIONAL MRI SIGNATURE FOR SPECIFIC DETECTION OF TRAUMATIC BRAIN INJURY IN VIVO US 63/061,105 Abandoned
NICHD E-169-2020-0-US-01 Identification Of An Inverse Agonist For The Human GPR101 Orphan Receptor US 63/060,484 Abandoned
NCATS E-027-2021-0-US-01 Quantum Dot Conjugated Virus Spike Protein For Cell-based Bio-sensing Systems And Drug Screening US 63/060,161 Abandoned
NCI E-190-2020-0-US-01 HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH G12V MUTATION US 63/060,340 Abandoned
NCI E-067-2017-0-HK-09 METHODS OF ISOLATING NEOANTIGEN-SPECIFIC T CELL RECEPTOR SEQUENCES HK EP 62020013025.5 Issued
NHLBI E-163-2019-0-PCT-02 Radiolabeled Sugars For Imaging Of Fungal Infections PCT PCT PCT/US2020/044446 Expired
NIA E-092-2011-0-US-12 USE OF (2R, 6R)-HYDROXYNORKETAMINE, (S)-DEHYDRONORKETAMINE AND OTHER STEREOISOMERIC DEHYDRO AND HYDROXYLATED METABOLITES OF (R,S)-KETAMINE IN THE TREATMENT OF DEPRESSION AND NEUROPATHIC PAIN US CON 16/945,163 Pending
NHLBI E-163-2019-0-EP-03 Radiolabeled Sugars For Imaging Of Fungal Infections EP National Stage 20757180.3 Pending
NIAID E-147-2015-0-ZA-15 BROADLY NEUTRALIZING MONOCLONAL ANTIBODIES AGAINST HIV-1 V1V2 ENV REGION ZA DIV 2020/04763 Pending
NCATS E-232-2020-0-US-01 MULTI-CYCLIC IRAK AND FLT3 INHIBITING COMPOUNDS AND USES THEREOF US 63/059,815 Abandoned
NCI E-215-2017-0-US-07 STEREOSELECTIVE SYNTHESIS AND PROCESS FOR THE MANUFACTURING OF 2'-DEOXYNUCLEOSIDES US National Stage 16/966,398 11365211 Issued PDF
NCI E-196-2018-0-US-01 INSERT FOR PREPARING CELL CULTURE CHAMBERS US 63/058,794 Abandoned
NHGRI E-083-2020-0-US-01 DIAGNOSIS AND TREATMENT OF VEXAS, WITH MOSAIC MISSENSE MUTATIONS IN UBA1 US 63/059,107 Abandoned
NCI E-176-2014-0-JP-53 ANTI-HUMAN PAPILLOMAVIRUS 16 E7 T-CELL RECEPTOR JP DIV 2020-127833 Issued
NINR E-134-2015-0-US-02 POINT OF NEED TESTING DEVICE AND METHODS OF USE THEREOF US DIV 16/941,333 Pending
NIDDK E-028-2018-1-AU-02 HETEROCYCLIC P2Y14 RECEPTOR ANTAGONISTS AU National Stage 2019218256 Abandoned
NCI E-227-2017-0-EP-03 PURIFICATION AND LABELING OF EXTRACELLULAR VESICLES USING
A MIXED MODE RESIN COMPOSITION 		EP National Stage 18847175.9 Issued
NCI E-227-2017-0-GB-01 PURIFICATION AND LABELING OF EXTRACELLULAR VESICLES USING
A MIXED MODE RESIN COMPOSITION 		GB EP 18847175.9 Issued
NCI E-227-2017-0-FR-01 PURIFICATION AND LABELING OF EXTRACELLULAR VESICLES USING
A MIXED MODE RESIN COMPOSITION 		FR EP 18847175.9 Issued
NCI E-227-2017-0-DE-01 PURIFICATION AND LABELING OF EXTRACELLULAR VESICLES USING
A MIXED MODE RESIN COMPOSITION 		DE EP 18847175.9 Issued
NCI E-068-2018-0-US-06 TETHERED INTERLEUKIN-15 AND INTERLEUKIN-21 US National Stage 16/964,796 Pending
NIDDK E-144-2019-2-US-01 Treatment And Prevention Of Neuropathic Pain With P2Y14 Antagonists US ORD 16/936,951 11708346 Issued PDF
NINDS E-201-2020-0-US-01 NANOBODIES DIRECTED TO CORONAVIRUS SPIKE PROTEIN RECEPTOR
BINDING DOMAIN AND USES THEREOF 		US 63/055,865 Abandoned
NICHD E-170-2020-0-US-01 TIME EFFICIENT MULTI-PULSED FIELD GRADIENT (MPFG) MRI WITHOUT CONCOMITANT GRADIENT FIELD ARTIFACTS US 63/055,150 Abandoned
NIAID E-033-2018-0-US-06 BROADLY PROTECTIVE INACTIVATED INFLUENZA VIRUS VACCINE US National Stage 16/963,718 11369675 Issued PDF
NIAID E-064-2015-3-US-01 MYELIN OLIGODENDROCYTE GLYCOPROTEIN, MYELIN BASIC PROTEIN, AND PROTEOLIPID PROTEIN COMPOSITIONS AND METHODS OF USE US CIP 16/934,573 Pending
NHLBI E-191-2020-0-US-01 SYSTEMS AND METHODS FOR MITRAL VALVE REPLACEMENT US 63/054,623 Abandoned
NIDDK E-028-2018-1-EP-05 HETEROCYCLIC P2Y14 RECEPTOR ANTAGONISTS EP National Stage 19707559.1 Pending
NCI E-021-2015-0-HK-30 Anti-CD70 Chimeric Antigen Receptors HK EP 42020011615.0 Issued